Holen Sie sich die Stockscreener-App
10.50
1.32%
-0.14
Handel nachbörslich:
10.47
-0.03
-0.29%
Schlusskurs vom Vortag:
$10.64
Offen:
$10.6
24-Stunden-Volumen:
6,367
Relative Volume:
5.00
Marktkapitalisierung:
$95.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$10.40
$10.60
1-Wochen-Bereich:
$10.34
$11.64
52-Wochen-Spanne:
$10.34
$11.64
Research Alliance Corp Iv Stock (RACD) Company Profile
Firmenname
Research Alliance Corp Iv
Sektor
Branche
Telefon
-
Adresse
-
Compare RACD vs LION, XXI, CCXI, UMAC, DMII
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RACD
Research Alliance Corp Iv
|
10.50 | 96.81M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
13.62 | 4.06B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.41 | 1.87B | 0 | 4.35M | 456.40K | 0.3397 |
CCXI
Churchill Capital Corp Xi
|
14.61 | 876.72M | 0 | 0 | 0 | 0.0647 |
UMAC
Unusual Machines Inc
|
16.64 | 885.14M | 17.25M | -5.64M | -40.16M | -0.3337 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.09 | 642.10M | 0 | 8.58M | -1.11M | 0.134 |
Research Alliance Corp Iv Aktie (RACD) Neueste Nachrichten
RACD SEC FilingsResearch Alliance Corp IV 10-K, 10-Q, 8-K Forms - Stock Titan
Research Alliance Corp IV (RACD) grants 275,000 shares to director entity - Stock Titan
Research Alliance Corp IV (RACD) sponsor gets 275K share grant - Stock Titan
Research Alliance Corporation IV (RACD) Stock Price, News & Analysis - MarketBeat
Research Alliance Corporation IV (RACD) seeks $75M SPAC IPO - Stock Titan
Book value per share of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
RACD Price Today: Research Alliance Corporation IV Stock Price, Quote & Chart - MEXC
Price to sales forward of Research Alliance Corporation IV – NASDAQ:RACD - TradingView
Research Alliance Corporation IV (RACD) 10K Form and Latest SEC Filings 2026 - MarketBeat
Research Alliance Corporation IV (RACD) Stock Trends and Sentiment 2026 - MarketBeat
Research Alliance Corporation IV Prices $75 Million IPO, Targets Healthcare Sector on Nasdaq - Minichart
Research Alliance IV Completes $75 Million SPAC IPO, Inks Trust, Underwriting and $2.75 Million Private Deal - TradingView
Research Alliance Corporation IV (RACD) completes $75M IPO and trust funding - Stock Titan
[S-1/A] Research Alliance Corp IV Amends IPO Registration Statement - Stock Titan
Research Alliance Corp IV (RACD) director reports 30K Class B convertible shares - Stock Titan
Research Alliance Corp IV (RACD) CFO files initial ownership statement - Stock Titan
Research Alliance Corp IV (RACD) officer Henry Stusnick files initial Form 3 - Stock Titan
Research Alliance IV prices $75M SPAC IPO - MSN
Research Alliance Corporation IV(NasdaqCM: RACD) added to NASDAQ Composite Index - marketscreener.com
Research Alliance Corporation IV prices $75 million IPO at $10.00 per share - scanx.trade
Research Alliance Corporation IV prices $75M IPO on Nasdaq By Investing.com - Investing.com South Africa
Research Alliance Corporation IV prices $75M IPO on Nasdaq - Investing.com
Research Alliance Corporation IV (RACD) Prices $75M IPO - SPACInsider
Research Alliance IV (RACD) Stock Price, News & Analysis - Stock Titan
RACD|Research Alliance IV Ord Shs Class A|Price:10.235|Chg%:-0.405 - TradingKey
Research Alliance Corp IV (RACD) launches $75M healthcare SPAC IPO - Stock Titan
[EFFECT] Research Alliance Corp IV SEC Filing - Stock Titan
Research Alliance Corporation IV has completed an IPO in the amount of $75 million. - marketscreener.com
Form S-1/A Research Alliance Corporation IV For: 8 July By Investing.com - Investing.com Nigeria
Lilly offers up to $1B for Alzheimer’s drug; Bial cuts failed Parkinson’s drug - Endpoints News
RA Capital banks $75M for a biotech SPAC - Yahoo Finance
New HighStock ScreenerSnapshot - Finviz
RA Capital targets China with latest SPAC deal - Yahoo Finance
CHAR Stock Price and Chart — NASDAQ:CHAR - TradingView
Finanzdaten der Research Alliance Corp Iv-Aktie (RACD)
Es liegen keine Finanzdaten für Research Alliance Corp Iv (RACD) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.92%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):